Both in Pharmaceuticals
Damora Therapeutics vs Opko Health
Over the past year DMRA returned −23.1% and OPK returned +3.2%; their daily moves had a correlation of 0.20.
DMRA −23.1% OPK +3.2%Growth of $1, one year, split-adjusted
| Metric | DMRA | OPK |
|---|---|---|
| Price | $21.61 | $1.62 |
| Market cap | $1.33B | $1.21B |
| Today | −1.59% | +0.62% |
| 1 month | +4.6% | 0.0% |
| 6 months | — | +45.9% |
| Year to date | — | +28.6% |
| 1 year | — | +11.7% |
| Revenue growth (YoY) | — | +4.3% |
| Gross margin | — | 48.9% |
| Net margin | — | −5.1% |
| P/E (TTM) | — | — |
| Price / sales | — | 2.1× |
| Net cash | $540.5M | -$46.5M |
| Dividend yield | — | — |
| Volatility (60d) | — | 57.8% |
| Short % of float | 11.2% | 9.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).